Abstract
Four commercially available systems for identification of yeasts were evaluated using 178 clinical isolates and seven reference strains previously identified by a conventional method. After 72 h of incubation, the rate of correct identification was 86.5 % with API20C Aux, 86 % with Auxacolor, 68 % with Mycotube and 51.1 % with Candifast. When considering only the reference strains included in the manufacturers' databases, the identification rate was 90 %, 91 %, 87 % and 61.2 % respectively. Although the results at 72 h obtained with API20C Aux and Auxacolor were similar, Auxacolor led to more rapid identification of the strains, 67.9 % versus 14.6 % being identified at 24h and 80.9 % versus 64 % being identified at 48 h.
Similar content being viewed by others
References
Anaissie EJ, Bodey GP, Rinaldi MG: Emerging fungal pathogens. European Journal of Clinical Microbiology and Infectious Diseases 1989, 8: 323–330.
Wenzel RP, Pfaller MA:Candida species: emerging hospital bloodstream pathogens. Infection Control and Hospital Epidemiology 1991, 12: 523–524.
Hoy J, Kuo-Ching S, Rolston K, Hopfer RL, Luna M, Bodey GP:Trichosporon beigelii infection: a review. Reviews of Infectious Diseases 1986, 8: 959–967.
Walling DM, McGraw DJ, Merz WG, Karp JE, Hutchings GM: Disseminated infection withTrichosporon beigelii. Reviews of Infectious Diseases 1987, 9: 1013–1019.
Blinkhorn RJ, Adelstein D, Spagnualo PJ: Emergence of a new opportunistic pathogen,Candida lusitaniae. Journal of Clinical Microbiology 1989, 27: 236–240.
Christenson JC, Guruswamy A, Mukwayo G, Rettig PJ:Candida lusitaniae: an emerging pathogen. Pediatric Infectious Disease Journal 1987, 6: 755–757.
St Germain G, Laverdière M:Torulopsis candida, a new opportunistic pathogen. Journal of Clinical Microbiology 1986, 24: 884–885.
Warren NG, Shadomy HJ: Yeasts of medical importance. In: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ (ed): Manual of clinical microbiology. American Society for Microbiology, Washington, DC, 1991, p. 617–629.
Hadfield TL, Smith MB, Winn RE, Rinaldi MG, Guerra C: Mycoses caused byCandida lusitaniae. Reviews of Infectious Diseases 1987, 9: 1006–1012.
Pappagianis D, Collins MJ, Hector R, Remington J: Development of resistance to amphotericin B inCandida lusitania infecting a human. Antimicrobial Agents and Chemotherapy 1979, 16: 123–126.
Pfaller MA, Rinaldi MG, Galgiani JN, Bartlett MS, Body BA, Espinel-Ingroff A, Fromtling RA, Hall GS, Hughs CE, Odds FC, Sugar AM: Collaborative investigation of variables in antifungal susceptibility testing of yeasts. Antimicrobial Agents and Chemotherapy 1990, 34: 1648–1654.
Shadomy S, Pfaller MA: Laboratory studies with antifungal agents: susceptibility tests and quantitation in body fluids. In: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ (ed): Manual of clinical microbiology. American Society for Microbiology, Washington, DC, 1991, p. 1173–1183.
Barnett JA, Payne RW, Yarrow D: Yeasts: characteristics and identification. Cambridge University Press, Cambridge, 1990.
Kreger-Van rij NJW: The yeasts, a taxonomic study. Elsevier, Amsterdam, 1984.
Buesching WJ, Kurek K, Roberts GD: Evaluation of the modified API20C system for identification of clinically important yeasts. Journal of Clinical Microbiology 1979, 9: 565–569.
Shinoda T, Kaufman L, Padhye AA: Comparison of the IATRON serological candida check-kit and the API 20C kit for identification of medically importantCandida species. Journal of Clinical Microbiology 1981, 13: 513–518.
Land GA, Harrison BA, Hulme KL, Cooper BH, Byrd JC: Evaluation of the new API 20C strip for yeasts identification against a conventional method. Journal of Clinical Microbiology 1979, 10: 357–364.
Bergan T, Hollum AB, Vangdal M: Evaluation of four commercial biochemical test systems for identification of yeasts. European Journal of Clinical Microbiology 1982, 1: 217–222.
Guinet RMF: Evaluation of the new Mycotube test-kit for yeast identification. European Journal of Clinical Microbiology 1985, 4: 10–13.
Dickgiesser NB, Pieringer E: Suitability of the modified API 20C, Mycotube and BactoCandida albicans antiserum for the identification of yeasts in the routine laboratory. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene 1980, 247: 132–137.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schuffenecker, I., Freydière, A., de Montclos, H. et al. Evaluation of four commercial systems for identification of medically important yeasts. Eur. J. Clin. Microbiol. Infect. Dis. 12, 255–260 (1993). https://doi.org/10.1007/BF01967255
Issue Date:
DOI: https://doi.org/10.1007/BF01967255